TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Nordic Bioscience A/S
Closing information (x1000 EUR)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover | 36,445 | 0 | 0 |
Earnings before taxes | 17,144 | 15,076 | 12,787 |
Total assets | 35,757 | 34,371 | 35,557 |
Current assets | 25,305 | 23,643 | 24,839 |
Current liabilities | 13,716 | 11,681 | 12,177 |
Equity capital | 15,832 | 15,240 | 16,077 |
- share capital | 1,345 | 1,344 | 1,339 |
Employees (average) | 150 | 150 | 75 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency | 44.3% | 44.3% | 45.2% |
Turnover per employee | 243 | 0 | 0 |
Profit as a percentage of turnover | 47.0% | ||
Return on assets (ROA) | |||
Current ratio | 184.5% | 202.4% | 204.0% |
Return on equity (ROE) | 108.3% | 98.9% | 79.5% |
Change turnover | 36,445 | 0 | 0 |
Change turnover % | |||
Chg. No. of employees | 0 | 75 | 0 |
Chg. No. of employees % | 0% | 100% | 0% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.